MarketCap
Facebook
X
TelegramQuarterly report 2023-Q2
added 08-02-2023
NuVasive EV/EBITDA Ratio 2011-2026 | NUVA
Annual EV/EBITDA Ratio NuVasive
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 16.3 | 32.5 | 26.1 | 19.5 | 17.9 | 28.2 | 20.9 | 32.9 | 36.9 | 17.5 | 21 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 36.9 | 16.3 | 24.5 |
EV/EBITDA Ratio of other stocks in the Medical devices industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
48.9 | $ 185.02 | -0.81 % | $ 13.9 B |  USA |
 |
Axonics Modulation Technologies
AXNX
|
-36 | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-4.45 | - | 1.37 % | $ 20.5 M | USA |
 |
Bruker Corporation
BRKR
|
-2.13 | $ 38.94 | -1.37 % | $ 5.8 K | USA |
 |
BioSig Technologies
BSGM
|
-1.88 | - | 37.08 % | $ 85.7 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-244 | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
-0.915 | - | -26.83 % | $ 2.62 M | USA |
 |
Conformis
CFMS
|
-44.1 | - | - | $ 16.4 M | USA |
 |
Avinger
AVGR
|
-2.46 | - | -20.74 % | $ 369 K | USA |
 |
AdaptHealth Corp.
AHCO
|
11 | $ 12.58 | -0.55 % | $ 1.7 B | USA |
 |
Allied Healthcare Products
AHPI
|
367 | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
-50.1 | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
-4.23 | - | -5.86 % | $ 30.6 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-4.76 | $ 0.61 | 3.18 % | $ 38 M | USA |
 |
EDAP TMS S.A.
EDAP
|
730 | $ 3.59 | 1.99 % | $ 134 M |  France |
 |
Boston Scientific Corporation
BSX
|
25.2 | $ 63.42 | -1.83 % | $ 93.9 B | USA |
 |
Apollo Endosurgery
APEN
|
-7.33 | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
-93.5 | - | 0.15 % | $ 844 M | USA |
 |
Eargo
EAR
|
-1.15 | - | - | $ 10.2 M | USA |
 |
ClearPoint Neuro
CLPT
|
-9.73 | $ 10.5 | 0.38 % | $ 297 M | USA |
 |
Dynatronics Corporation
DYNT
|
-2.59 | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
26.4 | $ 25.39 | -1.24 % | $ 215 M | USA |
 |
Second Sight Medical Products
EYES
|
3.87 | - | -0.97 % | $ 54.4 M | USA |
 |
CryoLife, Inc.
CRY
|
49.1 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
0.013 | - | 1.15 % | $ 34.5 M | USA |
 |
LENSAR
LNSR
|
-1.48 | $ 5.8 | -7.2 % | $ 69.4 M | USA |
 |
Soliton, Inc.
SOLY
|
-14 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
90.3 | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
1.03 | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-38.6 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
-12 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-20.2 | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
-165 | $ 16.53 | -7.39 % | $ 388 M | USA |
 |
Globus Medical
GMED
|
27.6 | $ 92.76 | -1.87 % | $ 12.5 B | USA |
 |
Helius Medical Technologies
HSDT
|
-0.0925 | $ 2.06 | 6.19 % | $ 1.25 M | USA |
 |
Butterfly Network
BFLY
|
-3.9 | $ 5.29 | 8.74 % | $ 1.12 B | USA |
 |
Intersect ENT, Inc.
XENT
|
-12.1 | - | - | $ 955 M | USA |
 |
Inogen
INGN
|
17.4 | $ 6.59 | 6.29 % | $ 175 M | USA |
 |
IRIDEX Corporation
IRIX
|
-11.2 | $ 1.04 | - | $ 17.6 M | USA |
 |
BIOLASE
BIOL
|
-86.3 | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
-1.69 | $ 10.83 | -1.46 % | $ 388 M | USA |
 |
Inspire Medical Systems
INSP
|
-152 | $ 56.45 | -0.34 % | $ 1.66 B | USA |
 |
CONMED Corporation
CNMD
|
40.2 | $ 37.91 | -3.88 % | $ 1.18 B | USA |
 |
LivaNova PLC
LIVN
|
215 | $ 65.01 | -0.2 % | $ 3.55 B |  Britain |
 |
Integer Holdings Corporation
ITGR
|
18.2 | $ 88.37 | 0.49 % | $ 3.07 B | USA |
 |
FONAR Corporation
FONR
|
-33.4 | $ 18.76 | -0.05 % | $ 123 M | USA |
 |
Invacare Corporation
IVC
|
1.89 | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
39.2 | $ 79.05 | 1.09 % | $ 46.2 B | USA |
 |
Sintx Technologies
SINT
|
0.974 | $ 2.68 | -2.19 % | $ 7.43 M | USA |
 |
Penumbra
PEN
|
938 | $ 331.47 | -0.29 % | $ 12.9 B | USA |